ArticleRSC advances2026
Microreactor-assisted synthesis of surface-active oxygen-rich Mn-Ce oxide particles and their catalytic activity in the wet air oxidation process.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a central-collision type microreactor was applied to the synthesis of Mn-Ce oxide catalysts by a liquid-phase oxidation method, which suffers from poor homogeneity and therefore has not been widely used in catalyst synthesis. This approach aimed to achieve improved structural homogeneity and oxygen defect formation. As a model reaction, phenol degradation by catalytic wet air oxidation was investigated using synthesized δ-type Mn-Ce oxides as catalysts. Compared with conventional stirring synthesis, microreactor-assisted synthesis afforded catalysts with finer and more uniform particles, larger specific surface areas, higher concentrations of surface oxygen species and bulk oxygen defects, and highly dispersed CeO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.